Robert J. Bitterman, Chairman, President & CEO at Phio Pharmaceuticals Corp. (PHIO), bought 4,200 shares at $1.78 ($7K) on 2025-05-22, disclosed to the SEC on 2025-05-23.
Open-market purchase of $7k PHIO by Chairman, President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.77 | 3,000 | $5K | 71.3% |
| 2 | $1.78 | 1,200 | $2K | 28.7% |
| Total | $1.77 avg | 4,200 | $7K | 100% |
| Filing → |
| PHIO | BUY | 2026-01-02 | $5K | — | Filing → |
| PHIO | BUY | 2025-12-29 | $5K | — | Filing → |
| PHIO | BUY | 2025-11-24 | $6K | — | Filing → |